'Chinese Vaccine Coronavac' - 4 News Result(s)
- Science | Press Trust of India | Tuesday June 29, 2021Two doses of the China-made COVID-19 vaccine, CoronaVac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a study published in The Lancet Infectious Diseases journal.
www.ndtv.com
- World News | Press Trust of India | Sunday June 6, 2021China has authorised the emergency use of CoronaVac, a COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17 years, Sinovac Chairman Yin Weidong said.
www.ndtv.com
- World News | Agence France-Presse | Thursday December 24, 2020Clinical trials of the CoronaVac coronavirus vaccine developed by Chinese laboratory Sinovac have "reached the efficacy threshold" demanded by the World Health Organization, the Brazilian institute charged with its production and distribution said on Wednesday.
www.ndtv.com
- World News | Agence France-Presse | Tuesday November 10, 2020Brazil's health regulator said Monday it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an "adverse incident" involving a volunteer recipient, a blow for one of the most advanced vaccine candidates.
www.ndtv.com
'Chinese Vaccine Coronavac' - 4 News Result(s)
- Science | Press Trust of India | Tuesday June 29, 2021Two doses of the China-made COVID-19 vaccine, CoronaVac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a study published in The Lancet Infectious Diseases journal.
www.ndtv.com
- World News | Press Trust of India | Sunday June 6, 2021China has authorised the emergency use of CoronaVac, a COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17 years, Sinovac Chairman Yin Weidong said.
www.ndtv.com
- World News | Agence France-Presse | Thursday December 24, 2020Clinical trials of the CoronaVac coronavirus vaccine developed by Chinese laboratory Sinovac have "reached the efficacy threshold" demanded by the World Health Organization, the Brazilian institute charged with its production and distribution said on Wednesday.
www.ndtv.com
- World News | Agence France-Presse | Tuesday November 10, 2020Brazil's health regulator said Monday it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an "adverse incident" involving a volunteer recipient, a blow for one of the most advanced vaccine candidates.
www.ndtv.com